| 产品详情 |
| Edit |   |
| Product Name | Recombinant Mycobacterium tuberculosis Toxin RelG (relG) |
| Description | Purity > 90% as determined by SDS-PAGE. MW: 26.2kDa. Full Length: 1-87aa. N-terminal 6xHis-SUMO-tagged. Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv). Toxic component of a toxin-antitoxin (TA) module. Has RNase activity and preferentially cleaves at the 3'-end of purine ribonucleotides. Overexpression in M.tuberculosis or M.smegmatis inhibits colony formation in a bacteriostatic rather than bacteriocidal fashion. Its toxic effect is neutralized by coexpression with cognate antitoxin RelB2 (shown only for M.smegmatis). Overexpression also increases the number of gentamicin-tolerant and levofloxacin-tolerant persister cells. |
| Size | 100ug |
| Concentration | n/a |
| Applications | RUO |
| Other Names | Putative endoribonuclease RelG |
| Gene, Accession, CAS # | relG, UniProt: O33348 |
| Catalog # | RPC22893 |
| Price | |
| Order / More Info | Recombinant Mycobacterium tuberculosis Toxin RelG (relG) from BIOMATIK |
| Product Specific References | n/a |
| 产品资料 |
|
|